These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 16219765)

  • 1. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of NFAT3 transcriptional activity by estrogen receptors.
    Qin X; Wang XH; Yang ZH; Ding LH; Xu XJ; Cheng L; Niu C; Sun HW; Zhang H; Ye QN
    Cell Mol Life Sci; 2008 Sep; 65(17):2752-62. PubMed ID: 18668201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
    Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue type-specific modulation of ER transcriptional activity by NFAT3.
    Zhang H; Wang X; Li J; Zhu J; Xie X; Yuan B; Yang Z; Zeng M; Jiang Z; Li J; Huang C; Ye Q
    Biochem Biophys Res Commun; 2007 Feb; 353(3):576-81. PubMed ID: 17194453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1.
    Zhao C; Gao H; Liu Y; Papoutsi Z; Jaffrey S; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2010 Jun; 70(12):5174-83. PubMed ID: 20501845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.
    Sisci D; Aquila S; Middea E; Gentile M; Maggiolini M; Mastroianni F; Montanaro D; Andò S
    Oncogene; 2004 Nov; 23(55):8920-30. PubMed ID: 15467744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
    Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.
    Saville B; Poukka H; Wormke M; Janne OA; Palvimo JJ; Stoner M; Samudio I; Safe S
    J Biol Chem; 2002 Jan; 277(4):2485-97. PubMed ID: 11696545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
    Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
    Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin.
    del Río B; García Pedrero JM; Martínez-Campa C; Zuazua P; Lazo PS; Ramos S
    J Biol Chem; 2004 Sep; 279(37):38294-302. PubMed ID: 15229223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.
    Grober OM; Mutarelli M; Giurato G; Ravo M; Cicatiello L; De Filippo MR; Ferraro L; Nassa G; Papa MF; Paris O; Tarallo R; Luo S; Schroth GP; Benes V; Weisz A
    BMC Genomics; 2011 Jan; 12():36. PubMed ID: 21235772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
    Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL
    Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
    Ding L; Niu C; Zheng Y; Xiong Z; Liu Y; Lin J; Sun H; Huang K; Yang W; Li X; Ye Q
    J Cell Mol Med; 2011 Jan; 15(1):72-85. PubMed ID: 19840196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PES1 promotes breast cancer by differentially regulating ERα and ERβ.
    Cheng L; Li J; Han Y; Lin J; Niu C; Zhou Z; Yuan B; Huang K; Li J; Jiang K; Zhang H; Ding L; Xu X; Ye Q
    J Clin Invest; 2012 Aug; 122(8):2857-70. PubMed ID: 22820289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.